Hydrazone derivatives and uses thereof
Details for Australian Patent Application No. 2006311826 (hide)
International Classifications
Event Publications
15 May 2008 PCT application entered the National Phase
PCT publication WO2007/056159 Priority application(s): WO2007/056159
11 November 2010 Application Accepted
Published as AU-B-2006311826
24 February 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 03 Feb 2011. Address for service in Australia - Peter Maxwell & Associates Level 6 60 Pitt Street Sydney NSW 2000
16 June 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 03 Feb 2011
23 June 2011 Standard Patent Sealed
31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006311827-High throughput screening assay for the TRPM5 ion channel
2006311820-Methods of using SAHA and erlotinib for treating cancer
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser